Oppenheimer took a bullish stance Tuesday on Canadian cannabis producer Hexo Corp HEXO, but said it's a speculative play given the uncertainty of the sector in which the company operates.
Analyst Rupesh Parikh initiated coverage of Hexo Corp. with an Outperform rating and $7 price target.
Oppenheimer's rating and price target is based on several key factors, including the long-term potential of the global cannabis industry, which the sell-side firm said could reach over $200 billion.
Hexo listed on the NYSE American exchange in January.
Hexo and beer maker Molson Coors Brewing Co TAP created a joint venture last year to produce non-alcoholic, cannabis-infused beverages for the Canadian market. Oppenheimer expects Hexo to launch partnerships in other categories, including cosmetics, edibles, vapes and more, Parikh said in the Tuesday initiation note.
Hexo's stock is trading at a discount to larger peers, the analyst said. For example, the shares are trading at a 13.8 forward 2020 EBITDA multiple, which is significantly lower than Tilray Inc. TLRY's multiple of 180.6 and Cronos Group Inc CRON's 54.7, he said.
Despite the bullish rating and optimistic price target, Parikh said the cannabis industry is still in its inception phase, and the competitive and regulatory backdrop is still evolving, making Hexo a more speculative investment versus other consumer packaged good verticals.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga Cannabis Conferences are coming to Los Angeles
Join the Benzinga Cannabis Market Spotlight: California, and unlock the future of cannabis at the premier networking event in Culver City on February 22. Connect with top industry leaders, gain insider insights into the investment landscape, and shape the evolving markets in California and beyond. Don’t miss this chance to be at the forefront of the cannabis industry’s growth and innovation! Join now.